Edaravone-Encapsulated Agonistic Micelles Rescue Ischemic Brain Tissue by Tuning Blood-Brain Barrier Permeability. - Wikidata - awgldk - TriplyDB

Edaravone-Encapsulated Agonistic Micelles Rescue Ischemic Brain Tissue by Tuning Blood-Brain Barrier Permeability.

Edaravone-Encapsulated Agonistic Micelles Rescue Ischemic Brain Tissue by Tuning Blood-Brain Barrier Permeability.

http://www.wikidata.org/entity/Q37738220

about

Poly(Ethylene Glycol)-Polylactide Micelles for Cancer Therapy.Image-guided chemotherapy with specifically tuned blood brain barrier permeability in glioma margins.

P2860

Q52584448-E06FA483-AF8B-4471-974C-7510C92C4C2E Q55365320-43DA3F07-5BC9-4111-B72E-0986768BC514

P2860

Edaravone-Encapsulated Agonistic Micelles Rescue Ischemic Brain Tissue by Tuning Blood-Brain Barrier Permeability.

http://www.wikidata.org/entity/Q37738220

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 08 February 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Edaravone-Encapsulated Agonist ...... od-Brain Barrier Permeability.

@en

Edaravone-Encapsulated Agonist ...... od-Brain Barrier Permeability.

@nl

type

label

Edaravone-Encapsulated Agonist ...... od-Brain Barrier Permeability.

@en

Edaravone-Encapsulated Agonist ...... od-Brain Barrier Permeability.

@nl

prefLabel

Edaravone-Encapsulated Agonist ...... od-Brain Barrier Permeability.

@en

Edaravone-Encapsulated Agonist ...... od-Brain Barrier Permeability.

@nl

P1433

Q37738220-F330F771-76C9-41C3-8607-4644A87674D3

P1476

Q37738220-66FA5FF9-7E29-4935-8695-5D44D386608B

P2093

Q37738220-0EBB0470-579E-4BF4-B9BF-36E76158B006

Q37738220-234D59B6-C0BD-40F4-AEB5-3383641CFE80

Q37738220-370D1898-06A9-4A1C-8FE0-A2F78BCC0954

Q37738220-52FEDA5F-A2AE-4194-BD79-92215EE983AD

Q37738220-651DA97D-2B98-4B51-9081-A5AB8F043467

Q37738220-659679C1-161A-4282-9456-881881715CBD

Q37738220-81711EF9-2494-4638-9B6C-ED3E1D39F8E8

Q37738220-C0D15037-E152-4F1C-953F-038CCC48BA3C

Q37738220-CCCA0BFC-98BD-4AC8-9B94-CC23B6312702

Q37738220-F749AF5F-CCBA-44C3-B711-CB6872121277

P2860

Q37738220-036D6C45-7140-433C-BDC6-D2AC2C8AC755

Q37738220-06A07818-CE44-49C6-95A7-24830283747E

Q37738220-083D502F-7639-47B7-8523-244056500728

Q37738220-129E3C4D-9E5A-4957-944F-8B012A78BD5C

Q37738220-12A01F35-0AD7-426D-A21E-AB13272B7A0D

Q37738220-2910E21E-3D6A-4E23-9446-6F48DB1F4ECE

Q37738220-31926A50-018A-4486-8716-268AF50C7C07

Q37738220-359D1335-E0AE-4775-AF84-5C90FF8100B1

Q37738220-3A448E9A-03D9-4B91-BB6C-0514173FB5EA

Q37738220-4E1B3BB0-C537-4C3B-89A5-EDB4434D7BC4

P304

Q37738220-23D3E15D-A68D-49C6-96FA-7250068C508F

P31

Q37738220-73D25390-AE91-4952-A055-61492310BCF6

P356

Q37738220-313D92B6-40C3-496C-A5FE-6811C774CB78

P433

Q37738220-0248E3E5-0F08-4980-8DC4-CD37029605E4

P478

Q37738220-5B2CE57C-8A48-4AB4-B8B9-80CCB199A19C

P50

Q37738220-C6805FB8-1EC7-4715-A586-366CA0F9C048

P577

Q37738220-BB907B35-24CB-414F-B19D-8604942EA9D5

P698

Q37738220-7BCB3402-E7DD-45BD-9234-20E0C4CD29EE

P921

Q37738220-1E72CBF4-2992-4308-901E-2ECC26C89B00

Q37738220-2169B028-BF9C-42D7-9CCE-0A406DA00BFF

Q37738220-9952F001-B377-4B47-BEA9-7E7D8D2D14DB

P932

Q37738220-9574DBFC-B54B-456F-8538-194671728D72

P356

P1433

P1476

Edaravone-Encapsulated Agonist ...... ood-Brain Barrier Permeability

@en

P2093

Chunqiang Lu

http://www.w3.org/2001/XMLSchema#string

Cong Li

http://www.w3.org/2001/XMLSchema#string

Haoran Liu

http://www.w3.org/2001/XMLSchema#string

Jun Qian

http://www.w3.org/2001/XMLSchema#string

Qu Jin

http://www.w3.org/2001/XMLSchema#string

Shenghong Ju

http://www.w3.org/2001/XMLSchema#string

Sihan Li

http://www.w3.org/2001/XMLSchema#string

Xihui Gao

http://www.w3.org/2001/XMLSchema#string

Xingyu Zhou

http://www.w3.org/2001/XMLSchema#string

Yu Cai

http://www.w3.org/2001/XMLSchema#string

P2860

Precise Characterization of the Penumbra Revealed by MRI: A Modified Photothrombotic Stroke Model Study

Caspases: killer proteases

The blood-brain barrier in health and chronic neurodegenerative disorders

Assessing post-stroke behavior in mouse models of focal ischemia.

Nanoprobes visualizing gliomas by crossing the blood brain tumor barrier.

Distinct effects of tissue-type plasminogen activator and SMTP-7 on cerebrovascular inflammation following thrombolytic reperfusion.

Recombinant tissue-type plasminogen activator use for ischemic stroke in the United States: a doubling of treatment rates over the course of 5 years.

Therapeutic benefits from nanoparticles: the potential significance of nanoscience in diseases with compromise to the blood brain barrier.

Nanoagonist-mediated endothelial tight junction opening: A strategy for safely increasing brain drug delivery in mice.

Potential markers of oxidative stress in stroke.

P304

884-898

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7150/THNO.18219

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-02-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28382161

http://www.w3.org/2001/XMLSchema#string

P921

blood–brain barrier

P932

5381251

http://www.w3.org/2001/XMLSchema#string